COVID-19: Navigating Remdesivir Results & Institutional Inertia

Cornelius J. Clancy, MD, discusses navigating partial trial information and the need for coherent national coordination on the COVID-19 response.

Segment Description: Cornelius J. Clancy, MD, discusses navigating partial trial information and the need for coherent national coordination on the COVID-19 response.

Related Videos
Related Content

Sales of These 4 Antibiotics Increased During the COVID-19 Pandemic

March 30th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Trust in Science Increased During the COVID-19 Pandemic, but Became More Polarized

March 29th 2023

Vaccine Inequity With Dr. Leonard Friedland

January 28th 2022

COVID-19 Exposure in Utero Linked to Neurodevelopmental Disorders in (Male) Offspring

March 28th 2023

Paxlovid Linked to Lower Risk of Long COVID

March 28th 2023

Sales of These 4 Antibiotics Increased During the COVID-19 Pandemic

March 30th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Trust in Science Increased During the COVID-19 Pandemic, but Became More Polarized

March 29th 2023

Vaccine Inequity With Dr. Leonard Friedland

January 28th 2022

COVID-19 Exposure in Utero Linked to Neurodevelopmental Disorders in (Male) Offspring

March 28th 2023

Paxlovid Linked to Lower Risk of Long COVID

March 28th 2023

Sales of These 4 Antibiotics Increased During the COVID-19 Pandemic

March 30th 2023

Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir

February 11th 2022

Trust in Science Increased During the COVID-19 Pandemic, but Became More Polarized

March 29th 2023

Vaccine Inequity With Dr. Leonard Friedland

January 28th 2022

COVID-19 Exposure in Utero Linked to Neurodevelopmental Disorders in (Male) Offspring

March 28th 2023

Paxlovid Linked to Lower Risk of Long COVID

March 28th 2023
© 2023 MJH Life Sciences

All rights reserved.